Evidence-Based Medicine Guidelines
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fluoropyrimidine-HAI (hepatic Arterial Infusion) Versus Systemic Chemotherapy (SCT) for Unresectable Liver Metastases From Colorectal Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450038/all/Fluoropyrimidine_HAI__hepatic_arterial_infusion__versus_systemic_chemotherapy__SCT__for_unresectable_liver_metastases_from_colorectal_cancer.
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450038/all/Fluoropyrimidine_HAI__hepatic_arterial_infusion__versus_systemic_chemotherapy__SCT__for_unresectable_liver_metastases_from_colorectal_cancer. Accessed February 7, 2023.
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450038/all/Fluoropyrimidine_HAI__hepatic_arterial_infusion__versus_systemic_chemotherapy__SCT__for_unresectable_liver_metastases_from_colorectal_cancer
Fluoropyrimidine-HAI (hepatic Arterial Infusion) Versus Systemic Chemotherapy (SCT) for Unresectable Liver Metastases From Colorectal Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 February 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450038/all/Fluoropyrimidine_HAI__hepatic_arterial_infusion__versus_systemic_chemotherapy__SCT__for_unresectable_liver_metastases_from_colorectal_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer
ID - 450038
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450038/all/Fluoropyrimidine_HAI__hepatic_arterial_infusion__versus_systemic_chemotherapy__SCT__for_unresectable_liver_metastases_from_colorectal_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
